Papp KA, Blauvelt A, Flack M, Gu Y, Thompson EH. Clinical Responses in Patients with Moderate-to-Severe Plaque Psoriasis Following Withdrawal and Re-Treatment with Risankizumab or Switching from Ustekinumab to Risankizumab. J of Skin [Internet]. 2017Oct.27 [cited 2024Oct.26];1(3.1):s5. Available from: https://skin.dermsquared.com/skin/article/view/77